What Happened
A Michigan pharmacist used the pharmacy he owned to sell more than 25,000 opioid pills for cash to a patient recruiter, including doses billed to people who never set foot in the store.
The pharmacist operated Great Health Pharmacy in Madison Heights, Michigan, which he used to distribute prescription drugs illegally, outside the course of usual professional pharmacy practice and for no legitimate medical purpose. He filled prescriptions brought to him by a co-defendant patient recruiter, in exchange for cash payments. At times, the prescriptions were dispensed in the names of patients who never came to the pharmacy; the recruiter would simply hand him a prescription without ever bringing the named patient in. At other times, he sold entire pharmacy stock bottles of controlled substances directly to the recruiter and others with no prescription at all.
He pleaded guilty to unlawfully dispensing 25,253 dosage units of Schedule II controlled substances, including oxycodone, oxymorphone, oxycodone-acetaminophen, and hydrocodone-acetaminophen, plus more than 200,000 milliliters of the Schedule V drug promethazine with codeine, along with money laundering. He was sentenced on February 9, 2023, in the U.S. District Court for the Eastern District of Michigan to 84 months in federal prison and ordered to forfeit approximately $1.2 million in cash seized during the investigation. His co-defendant, the patient recruiter, was separately sentenced to 72 months for the underlying drug trafficking conspiracy.
What Went Wrong
A pharmacy owner was able to fill cash prescriptions for phantom patients and sell stock bottles outright before the scheme was caught. Key failures included:
- Prescriptions were dispensed and billed to patients who never appeared at the pharmacy, with no process to verify a patient's physical presence or identity before dispensing.
- Cash payments for large controlled-substance prescriptions were not flagged as a red flag warranting corresponding-responsibility review.
- As the pharmacy's owner, he controlled both the dispensing and the oversight of his own controlled-substance transactions, with no independent check on stock-bottle sales made with no prescription.
How It Could Have Been Prevented
- Verify patient identity and presence before dispensing controlled substances, and flag prescriptions billed to patients with no verifiable pharmacy visit history.
- Treat cash payment for large quantities of Schedule II opioids as a corresponding-responsibility red flag requiring documented pharmacist review before filling.
- Require independent, external audit of a pharmacy owner's own controlled-substance dispensing and inventory activity, rather than relying on self-oversight.
- Reconcile stock-bottle inventory against actual patient-level dispensing records to catch bottles sold outside the prescription system.
Related Guidance
- Pharmacy Diversion Prevention Checklist — Self-assessment covering dispensing, corresponding responsibility, and inventory controls.
- Corresponding Responsibility Guide — Pharmacist obligations to verify legitimacy before filling controlled-substance prescriptions.
- 15 Red Flags of Drug Diversion — Transactional and prescribing indicators of pharmacy-level diversion.
- Diversion Penalties — Typical criminal, forfeiture, and licensure penalties in pharmacy diversion cases.
- More Diversion Case Studies — Additional documented cases of healthcare drug diversion.
Sources
- Madison Heights Pharmacist Sentenced for Diverting Over 25,000 Opioid Pills — U.S. Attorney's Office, Eastern District of Michigan. Sentenced February 9, 2023.